General contact

Main switchboard
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 a.m. - 5:00 p.m. GMT+1

US switchboard

+1 862 778 21 00
Monday - Friday,
8:30 a.m. - 5:00 p.m. EST

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

Investors

Investor Relations
Switzerland

Monday - Friday,
8:30 a.m. - 5:30 p.m. GMT+1
(Central European Time)

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

Our commitment: improving health

We aim to improve global health. Through our business, we make an important contribution to society: We discover and develop innovative healthcare products, targeting unmet medical needs. Novartis is the only healthcare company with leading positions in pharmaceuticals, eye care, generic medicines, vaccines, as well as consumer and animal health products.

Our patients and customers need to trust us and our products. They expect us to do business responsibly and ethically.

“We apply our expertise in science and innovation to society’s biggest health challenges. We take our role in improving health seriously and focus on areas where we can lead and make a significant impact.”

Joseph Jimenez, Chief Executive Officer, Novartis

Our medicines reach more than 1 billion people around the world each year. But the world is home to more than 7 billion people – all of whom have health needs.

Reaching more patients: expanding access to healthcare

Novartis collaborates with others to help address some of the world’s greatest health challenges. To help do that, our corporate responsibility programs help more people secure the healthcare they need, regardless of where they live. We’ve done this for a long time, largely through philanthropic and not-for-profit programs. We concentrate our work on efforts to control and eliminate diseases such as malaria and leprosy, pioneering new business approaches to reach underserved patients, and finding new treatments and adaptive solutions to improve health for people around the world. In 2013, these efforts reached more than 100 million patients.

The number of people in need continues to exceed the capacity of corporate philanthropy. So Novartis and other companies are turning to new ways of reaching people in need, by creating Social Ventures – shared value business models that complement philanthropic and zero-profit initiatives. Social Ventures are intended to be sustainable over the long term because they align the ambitions of society and business.

“As a science-based, innovative medicines company, we’re proud of our role in helping people live longer, healthier lives. The combination of responsible business and a focus on science is what drives us, and is the core of our corporate responsibility efforts. We take this responsibility very seriously – because it’s the right thing to do for society and the right thing to do for our business.”

Juergen Brokatzky-Geiger, Global Head, Corporate Responsibility

Doing business responsibly: performance with integrity

We recognize that we need to be responsible in our business operations.

We care for our associates, and provide them with a safe and healthy workplace, a living wage and opportunities to enhance their careers – regardless of their gender, race or background. We safeguard human rights in all of our operations.

We recognize that we are part of the communities where we do our work, and strive to positively contribute through alliances and volunteerism. When disasters happen, we do what we can to help.

We protect the environment, and minimize our energy use, emissions and impact of our products on the environment through measurement and management programs.

Our products are essential to our patients and customers, and we have rigorous business continuity plans in place to ensure a constant supply of our medicines.

As a healthcare company, our primary focus is research and development (R&D). We do encounter ethical questions as part of R&D, and welcome informed debate on these issues.

We conduct business ethically, and maintain a Code of Conduct and governance system to ensure our associates uphold our values.

We work with business partners who share our responsible approach.

Our company's shared commitment to corporate responsibility rests with every Novartis associate. Across Novartis, we aim for transparent reporting of annual targets and long-term objectives in all areas of our business, including corporate responsibility.